Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex.

[1]  B. Irons,et al.  Valsartan-Induced Angioedema , 2003, The Annals of pharmacotherapy.

[2]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[3]  T. Walther,et al.  AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  W. Tremaine,et al.  Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.

[5]  R. Carey,et al.  Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP , 2001, Hypertension.

[6]  A. Toutain,et al.  Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. , 2001, The Journal of allergy and clinical immunology.

[7]  Angelo Agostoni,et al.  Drug-Induced Angioedema without Urticaria , 2001, Drug safety.

[8]  K. Binkley,et al.  Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. , 2000, The Journal of allergy and clinical immunology.

[9]  K. Bork,et al.  Hereditary angioedema with normal C1-inhibitor activity in women , 2000, The Lancet.

[10]  J. Feenstra,et al.  Angioneurotic edema attributed to the use of losartan. , 1998, Archives of internal medicine.